HumiGard for preventing inadvertent perioperative hypothermia - guidance (MTG31)

National Institute for Health and Care Excellence - NICE
Publication date:
08 February 2017


Evidence-based recommendations on HumiGard for preventing inadvertent perioperative hypothermia.

Is this guidance up to date?

In February 2020, NICE is due to commence the review of this guidance, to register as a stakeholder please contact us at

Guidance development process

How we develop NICE medical technologies guidance

NICE medical technologies guidance addresses specific technologies notified to NICE by sponsors. The ‘case for adoption’ is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.

Clinical coding recommendations

Coding relevant to this guidance



1098871000000100 | Insufflation using warm humidified carbon dioxide (procedure)


13015901000001103 | HumiGard MR860 insufflation gas conditioning system (Fisher & Paykel Healthcare Limited) (physical object)